DEMANE MICHAEL F 4
4 · NEVRO CORP · Filed Jan 4, 2023
Insider Transaction Report
Form 4
NEVRO CORPNVRO
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2022-12-30+662→ 20,001 total
Holdings
- 82,541(indirect: See footnote)
Common Stock
- 18,266(indirect: See footnote)
Common Stock
- 164,344(indirect: See footnote)
Common Stock
- 91,225(indirect: See footnote)
Common Stock
Footnotes (7)
- [F1]Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
- [F2]Includes 4,155 restricted stock units.
- [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- [F4]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
- [F5]Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011 (the "2011 Trust").
- [F6]Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021 (the "2021 Trust").
- [F7]Reflects the transfer of 31,645 shares from the 2021 Trust to the 2011 Trust on November 18, 2022.